Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Anti-cyclic citrullinated peptide antibodies and joint involvement in Behçet's disease.

Cho SB, Lee JH, Ahn KJ, Bae BG, Kim T, Park YB, Lee SK, Lee KH, Bang D.

Yonsei Med J. 2012 Jul 1;53(4):759-64. doi: 10.3349/ymj.2012.53.4.759.

2.

Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis and Behçet's disease.

Koca SS, Akbulut H, Dag S, Artas H, Isik A.

Tohoku J Exp Med. 2007 Dec;213(4):297-304.

3.

What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?

Zhao Y, Li J, Li XX, Li C, Li L, Li ZG.

Joint Bone Spine. 2009 Oct;76(5):501-7. doi: 10.1016/j.jbspin.2008.11.007. Epub 2009 Mar 16.

PMID:
19289297
4.

The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.

Qing YF, Zhang QB, Zhou JG, Yuan GH, Wei J, Xing Y, Liu JP, Jiang L, Chen JP.

Lupus. 2009 Jul;18(8):713-7. doi: 10.1177/0961203309102817.

PMID:
19502267
5.

The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.

Popescu C, Zofotă S, Bojincă V, Ionescu R.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):179-87.

PMID:
24620631
6.

Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.

Habib HM, Mosaad YM, Youssef HM.

Immunol Invest. 2008;37(8):849-57. doi: 10.1080/08820130802438057.

PMID:
18991100
7.
8.

Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.

Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Kuwata S, Takeuchi F.

Clin Rheumatol. 2010 Mar;29(3):241-6. doi: 10.1007/s10067-009-1284-y. Epub 2009 Nov 29.

PMID:
20091076
9.

Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.

Payet J, Goulvestre C, Bialé L, Avouac J, Wipff J, Job-Deslandre C, Batteux F, Dougados M, Kahan A, Allanore Y.

J Rheumatol. 2014 Dec;41(12):2395-402. doi: 10.3899/jrheum.131375. Epub 2014 Oct 1. Erratum in: J Rheumatol. 2015 Mar;42(3):558.

PMID:
25274898
10.

Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.

Candia L, Marquez J, Gonzalez C, Santos AM, Londoño J, Valle R, Zabaleta J, Yaqub Z, Espinoza LR.

J Clin Rheumatol. 2006 Oct;12(5):226-9.

PMID:
17023808
11.

[Detecting anti-cyclic citrullinated peptide antibody in patients with connective tissue diseases].

Yin G, Cen XM, Yang M, Xie QB.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 May;42(3):374-7. Chinese.

PMID:
21827002
12.

Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.

Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ.

J Rheumatol. 2008 Jan;35(1):77-83. Epub 2007 Dec 15.

PMID:
18085741
13.

Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.

Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.

J Rheumatol. 2004 Sep;31(9):1829-33.

PMID:
15338508
14.

Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.

Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.

J Rheumatol. 2009 Apr;36(4):712-6. doi: 10.3899/jrheum.080653. Epub 2009 Mar 13.

PMID:
19286846
15.

[Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1].

Correa PA, Tobón GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM.

Biomedica. 2004 Jun;24(2):140-52. Review. Spanish.

PMID:
15495594
16.

Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity.

Li H, Song W, Li Y, Liu Y, Bai J, Li X, Mu F, Wang Y, Zhang F, Su L, Zhang F.

Clin Rheumatol. 2010 Apr;29(4):413-7. doi: 10.1007/s10067-009-1337-2. Epub 2010 Jan 5.

PMID:
20049501
17.

[Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].

Yang CL, Zhou YR, Zhou F, Li J.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Aug;27(8):1277-9. Chinese.

18.

Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients.

Skare TL, Nisihara R, Barbosa BB, da Luz A, Utiyama S, Picceli V.

Clin Rheumatol. 2013 Jul;32(7):1065-70. doi: 10.1007/s10067-013-2213-7. Epub 2013 Feb 15.

PMID:
23412637
19.

Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.

Jaskowski TD, Hill HR, Russo KL, Lakos G, Szekanecz Z, Teodorescu M.

J Rheumatol. 2010 Aug 1;37(8):1582-8. doi: 10.3899/jrheum.091236. Epub 2010 Jun 1.

20.

Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.

Damián-Abrego GN, Cabiedes J, Cabral AR.

Lupus. 2008 Apr;17(4):300-4. doi: 10.1177/0961203307087613.

PMID:
18413411

Supplemental Content

Support Center